Exercise or conversion by Mills C Randal of 44947 shares of Aziyo BiologicsInc subject to Rule 16b-3
About 67% of Aziyo Biologics' investor base is looking to short. The analysis of current outlook of investing in Aziyo Biologics suggests that many traders are alarmed regarding Aziyo Biologics' prospects. Aziyo Biologics' investing sentiment overview a quick insight into current market opportunities from investing in Aziyo Biologics. Many technical investors use Aziyo Biologics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aziyo |
Filed transaction by Aziyo Biologics Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Aziyo Biologics Fundamental Analysis
We analyze Aziyo Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aziyo Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aziyo Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Aziyo Biologics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Aziyo Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aziyo Biologics stock to make a market-neutral strategy. Peer analysis of Aziyo Biologics could also be used in its relative valuation, which is a method of valuing Aziyo Biologics by comparing valuation metrics with similar companies.
Peers
Aziyo Biologics Related Equities
AIMDW | Ainos | 46.67 | ||||
LNSR | LENSAR | 19.60 | ||||
AXGN | Axogen | 2.99 | ||||
OFIX | Orthofix Medical | 0.99 | ||||
ESTA | Establishment Labs | 0.80 | ||||
ELMD | Electromed | 0.78 | ||||
SGHT | Sight Sciences | 0.38 | ||||
NXL | Nexalin Technology | 0.37 | ||||
AORT | Artivion | 0.20 | ||||
CVRX | CVRx | 0.08 | ||||
AVNS | Avanos Medical | 1.05 | ||||
SSKN | STRATA Skin | 1.12 | ||||
ANIK | Anika Therapeutics | 1.25 | ||||
SRDX | SurModics | 1.26 | ||||
IRIX | IRIDEX | 4.17 | ||||
AIMD | Ainos | 5.36 | ||||
NVNO | EnVVeno Medical | 9.92 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Aziyo Stock
If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |